These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36494481)
1. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis. Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481 [TBL] [Abstract][Full Text] [Related]
2. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis. Meng W; Lu X; Wang G; Xiao Q; Gao J Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820 [TBL] [Abstract][Full Text] [Related]
3. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA. Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648 [TBL] [Abstract][Full Text] [Related]
4. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy. Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640 [TBL] [Abstract][Full Text] [Related]
5. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia. Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748 [TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes proliferation and G Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507 [TBL] [Abstract][Full Text] [Related]
7. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Ding Z; Guo L; Deng Z; Li P Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501 [TBL] [Abstract][Full Text] [Related]
8. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis. Li CH; Chan MH; Chang YC Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841 [TBL] [Abstract][Full Text] [Related]
9. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related]
10. The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A. Wang J; Li Z; Yang X; Qiao Y; Feng C; Yu S; Jing H; Liu W; Ren L; Duan Q; Li XQ; Cao W Carbohydr Polym; 2021 Mar; 255():117532. PubMed ID: 33436261 [TBL] [Abstract][Full Text] [Related]
11. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis. Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis. Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558 [TBL] [Abstract][Full Text] [Related]
14. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress. Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
17. miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA. Niu X; Wei N; Peng L; Li X; Zhang X; Wang C Malays J Pathol; 2022 Apr; 44(1):39-52. PubMed ID: 35484885 [TBL] [Abstract][Full Text] [Related]
18. Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma. Nabi AA; Atta SA; El-Ahwany E; Elzayat E; Saleh H Mol Biol Rep; 2021 Jul; 48(7):5549-5559. PubMed ID: 34313924 [TBL] [Abstract][Full Text] [Related]
19. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27. Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169 [TBL] [Abstract][Full Text] [Related]
20. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness. Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]